Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes

Zolikha Moazezi 1 and Durdi Qujeq 2 , 3 , *
Authors Information
1 Department of Internal Medicine, Babol University of Medical Sciences, Babol, IR Iran
2 Cellular and Molecular Biology Research Center, Babol University of Medical Sciences, Babol, IR Iran
3 Department of Biochemistry and Biophysics, Babol University of Medical Sciences, Babol, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 3, 2014, 9 (2); e13490
  • Published Online: April 7, 2014
  • Article Type: Research Article
  • Received: July 9, 2013
  • Revised: January 5, 2014
  • Accepted: January 28, 2014
  • DOI: 10.17795/jjnpp-13490

To Cite: Moazezi Z, Qujeq D. Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes, Jundishapur J Nat Pharm Prod. 2014 ; 9(2):e13490. doi: 10.17795/jjnpp-13490.

Copyright © 2014, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7): 1769-78[PubMed]
  • 2. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006; 29(11): 2471-6[DOI][PubMed]
  • 3. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006; 55(8): 2256-64[DOI][PubMed]
  • 4. Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. Biol Pharm Bull. 2005; 28(8): 1431-7[PubMed]
  • 5. Singh J, Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol. 2009; 123(1): 22-6[DOI][PubMed]
  • 6. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008; 22(8): 999-1012[DOI][PubMed]
  • 7. Cheng Z, Pang T, Gu M, Gao AH, Xie CM, Li JY, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta. 2006; 1760(11): 1682-9[DOI][PubMed]
  • 8. Peng WH, Wu CR, Chen CS, Chen CF, Leu ZC, Hsieh MT. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sci. 2004; 75(20): 2451-62[DOI][PubMed]
  • 9. Fatehi M, Saleh TM, Fatehi-Hassanabad Z, Farrokhfal K, Jafarzadeh M, Davodi S. A pharmacological study on Berberis vulgaris fruit extract. J Ethnopharmacol. 2005; 102(1): 46-52[DOI][PubMed]
  • 10. Yin J, Gao Z, Liu D, Liu Z, Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab. 2008; 294(1)-56[DOI][PubMed]
  • 11. Mikes V, Dadak V. Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. Biochim Biophys Acta. 1983; 723(2): 231-9[PubMed]
  • 12. Mikes V, Yaguzhinskij LS. Interaction of fluorescent berberine alkyl derivatives with respiratory chain of rat liver mitochondria. J Bioenerg Biomembr. 1985; 17(1): 23-32[PubMed]
  • 13. Barreto MC, Pinto RE, Arrabaca JD, Pavao ML. Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. Toxicol Lett. 2003; 146(1): 37-47[PubMed]
  • 14. Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008; 57(5): 1414-8[DOI][PubMed]
  • 15. Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism. 2009; 58(1): 109-19[DOI][PubMed]
  • 16. Ni YX, Liu AQ, Gao YF, Wang WH, Song YG, Wang LH, et al. Therapeutic effect of berberine on 60 patients with non-insulin dependent diabetes mellitus and experimental research. Chin J Int Tradit West Med. 1995; 1(2): 91-5[DOI]
  • 17. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008; 57(5): 712-7[DOI][PubMed]
  • 18. Bunn HF, Haney DN, Gabbay KH, Gallop PM. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun. 1975; 67(1): 103-9[PubMed]
  • 19. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med. 1971; 284(7): 353-7[DOI][PubMed]
  • 20. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML. Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med. 1977; 86(4): 425-9[PubMed]
  • 21. Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF, Gallop PM. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab. 1977; 44(5): 859-64[DOI][PubMed]
  • 22. Gonen B, Rubenstein A, Rochman H, Tanega SP, Horwitz DL. Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet. 1977; 2(8041): 734-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments